Gordon Mcvie

Professor John Gordon McVie FRCPE FRCPSGlas FRCP FMedSci DSc (born 13 January 1945) is an international authority on the treatment and research of cancer. Along with Umberto Veronesi he is the founding editor of ecancer.org, an open-access cancer platform. He has written over 300 peer-reviewed papers and editorials as well as contributing to numerous books. He has served on several committees including the American Association for Cancer Research and the American Society of Clinical Oncology, and the boards of the National Cancer Institutes of France, Italy and the Netherlands. In the UK, he has served on the boards of cancer institutes including the Beatson Institute for Cancer Research, the Institute for Cancer Research, and the Christie Hospital. He is currently Director of Cancer Intelligence, providing advisory services to the media, patients, pharmaceutical and biotechnology companies as well as publishing ecancer.org. McVie is currently the Clinical Consultant to the European Institute of Molecular Oncology (IFOM), and a Visiting Professor at King's College London. He chairs the Board of Proton Partners (International) Limited and is a non-executive director of Ellipses Pharma. He has formulated several substantial additions to the field of cancer care including establishing localised, more pin-point, administration of chemotherapy, and encouraging the use of chemotherapy for the treatment of lung cancer throughout the EU. He has also emphasised the importance of adjusting a patient's management according to their ethnicity.